"10.1371_journal.pone.0122835","plos one","2015-04-09T00:00:00Z","Clarisse Lorin; Yannick Vanloubbeeck; Sébastien Baudart; Michaël Ska; Babak Bayat; Geoffroy Brauers; Géraldine Clarinval; Marie-Noëlle Donner; Martine Marchand; Marguerite Koutsoukos; Pascal Mettens; Joe Cohen; Gerald Voss","GSK Vaccines, Rixensart, Belgium","Conceived and designed the experiments: CL YV MK GV JC BB PM. Performed the experiments: SB MS GB GC BB MND. Analyzed the data: CL YV BB. Wrote the paper: CL YV SB MS BB GB GC MND MM MK PM JC GV.","All authors declared that the following interests are relevant to the submitted work: All authors are, or were at the time of the study, employees of the GSK group of companies. JC now works as an independent consultant for GSK Vaccines. CL, YV, MK, GV, JC and PM report ownership of GSK shares. JC, CL, MK and GV are listed as inventors on patents owned by GSK. The F4 construct is disclosed in patent WO2006/013106: Vaccine for prevention and treatment of HIV-infection. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Clarisse Lorin","CL",13,TRUE,7,6,3,13,TRUE,TRUE,FALSE,0,NA,FALSE
